Elanco Animal Health ($ELAN) Insider Trading & Smart Money Activity
Elanco Animal Health Incorporated ($ELAN) has 3 insider trades, 2 13F position changes and 2 analyst ratings on file. Insiders filed 3 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 0
- Net insider $ (12 mo)
- $0
- Congress trades (12 mo)
- 0
- 13F moves on file
- 2
- Analyst ratings on file
- 2
ELAN insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 0 / 2 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All ELAN insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Analyst | Goldman Sachs | Reiterates to Buy | PT $32 | Read | |||||||
| Insider | Robert VanhimbergenEVP and CFO | Buy (Grant or award) | 8 sh | $196.56 | +2.3% | +3.4% | — | ||||
| Insider | Jeffrey SimmonsPRESIDENT, CEO AND DIRECTOR | Buy (Grant or award) | 115 sh | $2.83K | +2.3% | +3.4% | Read | ||||
| Analyst | TD Cowen | Reiterates to buy | PT $32 | +0.6% | +3.8% | Read | |||||
| Insider | Jeffrey SimmonsPRESIDENT, CEO AND DIRECTOR | Buy (Grant or award) | 117 sh | $2.83K | -1.1% | +4.0% | — | ||||
| 13F | T. Rowe Price Investment Management | Reduced | -592.33K sh | $852.37M | +9.4% | +22.3% | — | ||||
| 13F | Dodge & Cox | Reduced | -10.14M sh | $1.71B | -1.5% | +12.2% | Read |
1W / 1M / 6M = how ELAN moved from the trade or filing date.
Insider trading in ELAN: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Jeffrey Simmons | PRESIDENT, CEO AND DIRECTOR | 2 | — | Jun 26, 2026 | |
| Robert Vanhimbergen | EVP and CFO | 1 | — | Jun 26, 2026 |
Institutions moving ELAN (13F)
Analyst ratings on ELAN
Frequently asked questions
What is the latest insider trade in ELAN?
Robert Vanhimbergen, EVP and CFO filed a buy (grant or award) of 8 sh worth $196.56 on Jun 26, 2026.
Which institutions changed their ELAN positions?
Recent 13F filers moving the stock include T. Rowe Price Investment Management and Dodge & Cox.
Other drug manufacturers - specialty & generic stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.